Huanhuan LUO

Dr. Huanhuan LUO


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2023 in EBioMedicine
Verified
Journal Article
Open access
YWYalan Wu
Yalan Wu
XFXiangrong Feng
Xiangrong Feng
MLMengjun Li
Mengjun Li
ZHZongren Hu
Zongren Hu
YZYuhua Zheng
Yuhua Zheng
HLHuanhuan LUO
Huanhuan LUO
Food is crucial for maintaining vital human and animal activities. Disorders in appetite control can lead to various metabolic disturbances. Alterations in the gut microbial composition can affect appetite and energy metabolism. While alterations in the gut microbiota have been observed in high-temperature and high-humidity (HTH) environments, the relationship between the gut microbiota during HTH and appetite remains unclear. We utilised an artificial climate box to mimic HTH environments, and established a faecal bacteria transplantation (FMT) mouse model. Mendelian randomisation (MR) analysis was used to further confirm the causal relationship between gut microbiota and appetite or appetite-related hormones. We found that, in the eighth week of exposure to HTH environments, mice showed a decrease in food intake and body weight, and there were significant changes in the intestinal microbiota compared to the control group. After FMT, we observed similar changes in food intake, body weight, and gut bacteria. Appetite-related hormones, including ghrelin, glucagon-like peptide-1, and insulin, were reduced in DH (mice exposed to HTH conditions) and DHF (FMT from mice exposed to HTH environments for 8 weeks), while the level of peptide YY initially increased and then decreased in DH and increased after FMT. Moreover, MR analysis further confirmed that these changes in the intestinal microbiota could affect appetite or appetite-related hormones. Together, our data suggest that the gut microbiota is closely associated with appetite suppression in HTH. These findings provide novel insights into the effects of HTH on appetite. This work was supported by the National Natural Science Foundation of China and Guangzhou University of Chinese Medicine.

10 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSong Chen
Song Chen
YZYuhua Zheng
Yuhua Zheng
YZYiqing Zhou
Yiqing Zhou
WGWeizhong Guo
Weizhong Guo
QTQin Tang
Qin Tang
HLHuanhuan LUO
Huanhuan LUO
High temperature and humidity (HTH) can cause diarrhea owing to food and drinking water contamination. However, their direct effects on gut microbiota and gastrointestinal inflammation are unknown. This study aimed to investigate the effects of HTH and probiotics on the microbiome. Twenty-one male mice were randomly assigned to normal control (NC), HTH, and broad-spectrum probiotic-treated (PR) groups. HTH and PR groups were regularly housed at 30 ± 0.5 °C with humidity of 85–90% for eight consecutive weeks. A broad-spectrum probiotic was administrated to PR-group mice from day 50 to 56. Clinical signs were observed and gut microbiota were analyzed via 16 S rRNA-based functional metagenomics. Intestinal pathology and the expression of defensins and pro-inflammatory cytokines were also assessed. Mice in the HTH and PR groups gradually developed sticky or loose feces. The HTH group developed a distinct microbiota profile associated with augmented metabolism and human-like pathophysiologies upon suppression of environmental sensing. Pathological assays indicated minimal enteritis, increased bacterial translocation, and elevated intestinal pro-inflammatory cytokine levels. Thus, ambient HTH directly contributes to gut dysbiosis and minimal enteritis, whereas probiotics partially normalized the microbiota and ameliorated gut inflammation. This study provides novel insights into the pathogenesis of environment-associated diseases and offers a potential therapeutic approach.

1 September 2016 in Molecular & Cellular Toxicology
Verified
Journal Article
Closed access
PDF file
HLHuanhuan LUO
Huanhuan LUO
LLLiang Li
Liang Li
JTJianbang Tang
Jianbang Tang
FZFengxue Zhang
Fengxue Zhang
FZFang Zhao
Fang Zhao
XWXinhua Wang
Xinhua Wang

16 January 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
YWYalan Wu
Yalan Wu
XFXiangrong Feng
Xiangrong Feng
JLJinmei Li
Jinmei Li
MLMengjun Li
Mengjun Li
YWYao Wang
Yao Wang
HLHuanhuan LUO
Huanhuan LUO
Aging populations are susceptible to climate change due to physiological factors and comorbidities. Most relevant studies reported the effect of temperature on cardiovascular disease (CVD)-related mortality in aging populations. However, the combined effects of temperature and humidity on CVD-related mortality remain unclear. Here we used the Global Burden of Disease (GBD) database to analyze CVD burden and its impact on the incidence of CVD in individuals exposed to high-temperature and high-humidity (HTH) environments. The prospective China Health and Retirement Longitudinal Study (CHARLS) cohort was used to further analyze the relationship between exposure to HTH environments and CVD mortality in middle-aged and elderly individuals. We found significant positive correlations between the estimated annual percentage change of CVD and age-standardized rate, wet bulb globe temperature, and Humidex worldwide. In the CHARLS, a higher CVD mortality rate was significantly associated with exposure to HTH environments (P < 0.01). Long-term HTH environment exposure increased the risk of an abnormal low-density lipoprotein cholesterol (LDL-C) level (hazard ratio [HR], 1.30-2.44) and abnormal total cholesterol (TC) level (HR, 1.21-2.13), but the impact on high-density lipoprotein cholesterol (HDL-C) level was unclear. The mortality risks of long-term exposure to HTH environments were increased for middle-aged and elderly individuals with abnormal LDL-C (HR = 0.84-3.57) and TC (HR = 0.78-2.41) levels. These findings suggest that exacerbated dyslipidemia caused by long-term HTH environment exposure may be a key risk factor for CVD-related mortality in middle-aged and elderly individuals and suggest research directions into the effects of HTH environments on human health.

1 April 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
HLHuanhuan LUO
Huanhuan LUO
FZFang Zhao
Fang Zhao
FZFengxue Zhang
Fengxue Zhang
NLNi Liu
Ni Liu
The aim of the present study was to elucidate the mechanism of amygdalin treatment on reducing liver fibrosis by investigating its role in regulating the expression level of platelet-derived growth factor (PDGF), insulin-like growth factor (IGF) and PDGF receptor (PDGFR) in the hepatic stellate cell (HSC)-T6 line. HSC-T6 cells were used as an in vitro model and randomly assigned into four groups: control, high-dose amygdalin, mid-dose amygdalin and low-dose amygdalin. Following amygdalin treatment, compared with the control, a high dose of amygdalin significantly suppressed the mRNA expression of PDGF and IGF (each P<0.05), whereas moderate and low doses showed no significant effect, relatively low doses of amygdalin are not sufficient to transfer signals to its receptor. The high-dose amygdalin and low-dose amygdalin displayed suppressed protein expression of PDGF at 24, 48 and 72 h, with the high-dose group exhibiting the most marked suppression at all three time points. By reducing the transcription of PDGF and IGF mRNA and the expression of PDGF protein, amygdalin decreased the synthesis and release of PDGF and IGF, thereby reducing the influence of PDGF and IGF on HSCs, thus protecting the liver from fibrosis.

28 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YLYi Luo
Yi Luo
ZWZiguang Wu
Ziguang Wu
SCSong Chen
Song Chen
HLHuanhuan LUO
Huanhuan LUO
XMXiaoying Mo
Xiaoying Mo
JTJianbang Tang
Jianbang Tang
Whether the relationship between type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) can be solely attributed to the shared risk factors, such as obesity, remains controversial. Several studies have revealed the critical role of abnormal glycosylation in the pathogenesis of OA and T2DM. Therefore, we speculate that T2DM may contribute to the pathogenesis of OA through the intrinsic mechanisms of N-glycosylation aberrations. Using N-glycoproteomics, we compared the changes in N-glycosylated protein abundance in cartilage samples from patients with OA without and with T2DM (DM-OA), and from patients with traumatic joint injury (NC) as controls. We identified 847 N-glycosylation sites corresponding to 729 peptides fragments from 374 proteins. The number of N-glycosylated proteins in the DM-OA group tended to decrease compared with that in the OA and NC groups. We identified 22 upregulated and 1 down-regulated N-glycosylated peptides in the OA group compared to the NC group, while only fibronectin 1 (FN1) at position N1007, cartilage intermediate layer protein 1 (CILP) at N346, and collagen type VI alpha 1 chain (COL6A1) at N804, were also identified in the DM-OA group. Compared to the OA group, the downregulation of secreted protein acidic and rich in cysteine (SPARC) at N116, collagen type VI alpha 1 chain (COL6A2) at N785, and asporin (ASPN) at N282, and the upregulation of complement component C8 alpha chain (C8α) at N437, were the most remarkable alterations in the DM-OA group. The differentially expressed N-glycosylated proteins between the OA and DM-OA groups were mainly located extracellularly and enriched in the KEGG pathways involving PI3K/Akt signaling, focal adhesion, and ECM-receptor interaction. Their predicted protein–protein interactions were also depicted. We were thus able to show the general characteristics of N-glycosylation aberrations in OA and DM-OA. Moreover, the upregulated glycosylated complement C8α in the DM-OA group might augment membrane attack complex activity, thereby exacerbating cartilage destruction. Although further confirmation is required, our hypothesis proposes a possible explanation for the deduction that T2DM is an independent risk factor for OA.